Simulated microgravity accelerates alpha-synuclein aggregation and induces oxidative stress in an in vitro Parkinson’s disease model
Preprint
Abstract
Parkinson’s disease (PD) is a neurodegenerative disorder characterized by the accumulation of alpha-synuclein aggregates and progressive neuronal loss in the substantia nigra, with aging being its primary risk factor. The current available models to study PD mechanisms are largely relying on genetic mutations to recapitulate PD typical hallmarks, such as increased alpha-synuclein aggregation. However, they do not model the aging features associated with the disease. Microgravity, a condition experience by astronauts during space missions, is known to induce ageing-like modifications on both systemic and cellular physiology. To replicate the aging-related stress observed in PD patients, we exposed SH-SY5Y and 3K-SNCA mutant cell lines to simulated microgravity. Our findings revealed that simulated microgravity enhanced PD alterations, with a significant increase in misfolded and phosphorylated a-syn. This was accompanied by heightened oxidative stress, as evidenced by increased levels of reactive oxygen species, without a sufficient antioxidant response. These results suggest that simulated microgravity effectively mimics and accelerate the stress associated with aging in PD cell models, regardless of the presence of PD mutation. This study highlights the potential of simulated microgravity as a tool for investigating aging processes in neurodegenerative diseases.Keywords
This publication has 82 references indexed in Scilit:
- α-Synuclein misfolding and aggregation: Implications in Parkinson’s disease pathogenesisBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2019
- N370S‐GBA1 mutation causes lysosomal cholesterol accumulation in Parkinson's diseaseMovement Disorders, 2017
- MDS clinical diagnostic criteria for Parkinson's diseaseMovement Disorders, 2015
- The regulation of catalase activity by PPAR γ is affected by α ‐synucleinAnnals of Clinical and Translational Neurology, 2014
- Glucocerebrosidase deficiency in substantia nigra of parkinson disease brainsAnnals of Neurology, 2012
- Etiology and pathogenesis of Parkinson's diseaseMovement Disorders, 2011
- Chaperone-Mediated Autophagy Markers in Parkinson Disease BrainsArchives of Neurology, 2010
- PINK1 mutations in sporadic early‐onset Parkinson's diseaseMovement Disorders, 2006
- Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydesFree Radical Biology and Medicine, 1991
- Mechanism of activation of glucocerebrosidase by CO-β-glucosidase (glucosidase activator protein)Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1981